Ava Avalos

1.3k citations

27 papers · 989 indexed · h-index 19

Impact in

Virology top 1%
- HIV Research and Treatment
Infectious Diseases top 2%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment

Papers in ⓘ

Virology 17
- HIV Research and Treatment 17
Infectious Diseases 23
- HIV/AIDS Research and Interventions 19
- HIV/AIDS drug development and treatment 16
- Tuberculosis Research and Epidemiology 2

Co-authors: Tendani Gaolathe (10 shared papers)Max Essex (10 shared papers)Ndwapi Ndwapi (9 shared papers)Richard Marlink (7 shared papers)Diana Dickinson (4 shared papers)Hermann Bussmann (6 shared papers)Madisa Mine (7 shared papers)Howard Moffat (7 shared papers)
Journals: Clinical Infectious Diseases (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)AIDS (2 papers)Viruses (2 papers)PLoS ONE (2 papers)
Partner nations: United States Botswana United Kingdom

In The Last Decade

Ava Avalos

27 papers receiving 957 citations

Peers

Countries citing papers authored by Ava Avalos

Since Specialization

Citations

This map shows the geographic impact of Ava Avalos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ava Avalos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ava Avalos more than expected).

Fields of papers citing papers by Ava Avalos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ava Avalos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ava Avalos. The network helps show where Ava Avalos may publish in the future.

Co-authors

The 25 scholars most cited alongside Ava Avalos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ava Avalos Line = papers co-authored together Ava Avalos links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program AIDS ·Hermann Bussmann, C. William Wester, Ndwapi Ndwapi, Nicolas K. Grundmann, Tendani Gaolathe, John P.A. Puvimanasinghe, Ava Avalos, Madisa Mine, Khumo Seipone, Max Essex, Victor DeGruttola, Richard Marlink	2008	128
2	Initial Response to Highly Active Antiretroviral Therapy in HIV-1C-Infected Adults in a Public Sector Treatment Program in Botswana JAIDS Journal of Acquired Immune Deficiency Syndromes ·C. William Wester, Soyeon Kim, Hermann Bussmann, Ava Avalos, Ndwapi Ndwapi, Trevor Peter, Tendani Gaolathe, Andrew Mujugira, Lesego Busang, Chris Vanderwarker, Peter Cardiello, Onalethata Johnson, Ibou Thior, Patson Mazonde, Howard Moffat, Max Essex, Richard Marlink	2005	104
3	Overestimates of Survival after HAART: Implications for Global Scale-Up Efforts PLoS ONE ·Gregory P. Bisson, Tendani Gaolathe, Robert Gross, Caitlin K. Rollins, Scarlett L. Bellamy, Mpho Mogorosi, Ava Avalos, Harvey Friedman, Diana Dickinson, Ian Frank, Ndwapi Ndwapi	2008	101
4	High Prevalence of the K65R Mutation in Human Immunodeficiency Virus Type 1 Subtype C Isolates from Infected Patients in Botswana Treated with Didanosine-Based Regimens Antimicrobial Agents and Chemotherapy ·Florence Doualla‐Bell, Ava Avalos, Bluma Brenner, Tendani Gaolathe, Madisa Mine, Simani Gaseitsiwe, Maureen Oliveira, Daniella Moisi, Ndwapi Ndwapi, Howard Moffat, Max Essex, Mark A. Wainberg	2006	88
5	The relationship of acceptance or denial of HIV-status to antiretroviral adherence among adult HIV patients in urban Botswana Social Science & Medicine ·Sara L. Nam, Katherine Fielding, Ava Avalos, Diana Dickinson, Tendani Gaolathe, P. Wenzel Geißler	2008	80
6	Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis The Lancet Global Health ·Mansour Farahani, Anusha M. Vable, Refeletswe Lebelonyane, Khumo Seipone, M. Anderson, Ava Avalos, Tim Chadborn, Tilahun Hailu, Danae Roumis, Themba Moeti, Godfrey Musuka, Lesego Busang, Tendani Gaolathe, Kolaatamo C S Malefho, Richard Marlink	2013	52
7	Caring for the Caregivers: Models of HIV/AIDS Care and Treatment Provision for Health Care Workers in Southern Africa The Journal of Infectious Diseases ·Kerry Uebel, Jenny Nash, Ava Avalos	2007	48
8	Serological Evidence of HIV-Associated Infection among HIV-1--Infected Adults in Botswana Clinical Infectious Diseases ·C. William Wester, Hermann Bussmann, Sikhulile Moyo, Ava Avalos, Tendani Gaolathe, N. Ndwapi, Max Essex, R. R. MacGregor, Richard Marlink	2006	43
9	Safety and efficacy of nevirapine- and efavirenz-based antiretroviral treatment in adults treated for TB-HIV co-infection in Botswana. PubMed ·Linda Shipton, C. William Wester, Susan Stock, N. Ndwapi, Tendani Gaolathe, Ibou Thior, Ava Avalos, Howard Moffat, J. J. Mboya, Erik Widenfelt, Max Essex, Michael D. Hughes, Roger Shapiro	2009	43
10	Infection of hematopoietic progenitor cells by HIV-1 subtype C, and its association with anemia in southern Africa Blood ·Andrew D. Redd, Ava Avalos, Max Essex	2007	34
11	Establishment of a Public Antiretroviral Treatment Clinic for Adults in Urban Botswana: Lessons Learned Clinical Infectious Diseases ·C. William Wester, Hermann Bussmann, Ava Avalos, Ndwapi Ndwapi, Tendani Gaolathe, Peter Cardiello, Christine Bussmann, Howard Moffat, Patson Mazonde, Richard Marlink	2005	30
12	Implementing HIV-1 genotypic resistance testing in antiretroviral therapy programs in Africa: needs, opportunities, and challenges. PubMed ·Richard Lessells, Ava Avalos, Túlio de Oliveira	2014	30
13	Discussing matters of sexual health with children: what issues relating to disclosure of parental HIV status reveal AIDS Care ·Sara L. Nam, Katherine Fielding, Ava Avalos, Tendani Gaolathe, Diana Dickinson, P. Wenzel Geißler	2009	29
14	Impact of Human Immunodeficiency Virus Type 1 Subtype C on Drug Resistance Mutations in Patients from Botswana Failing a Nelfinavir-Containing Regimen Antimicrobial Agents and Chemotherapy ·Florence Doualla‐Bell, Ava Avalos, Tendani Gaolathe, Madisa Mine, Simani Gaseitsiwe, Ndwapi Ndwapi, Vladimir Novitsky, Bluma Brenner, Maureen Oliveira, Daniella Moisi, Howard Moffat, Ibou Thior, Max Essex, Mark A. Wainberg	2006	24
15	Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review Viruses ·Carolyn Chu, Kaiming Tao, Vinie Kouamou, Ava Avalos, Jake Scott, Philip Grant, Soo‐Yon Rhee, Suzanne M. McCluskey, Michael R. Jordan, Rebecca L. Morgan, Robert W. Shafer	2024	23
16	Mutations and Polymorphisms Associated with Antiretroviral Drugs in HIV-1C-Infected African Patients Antiviral chemistry & chemotherapy ·Florence Doualla‐Bell, S. Gaseitsiwe, Thumbi Ndung’u, Musetsanagepe Modukanele, Trevor Peter, Vladimir Novitsky, Ndwapi Ndwapi, Tendani Gaolathe, Ava Avalos, W. C. Wester, Hermann Bussmann, Peter Cardiello, Richard Marlink, Howard Moffat, Ibou Thior, Mark A. Wainberg, Max Essex	2004	21
17	Four-class drug-resistant HIV-1 subtype C in a treatment experienced individual on dolutegravir-based antiretroviral therapy in Botswana AIDS ·Kaelo K. Seatla, Ava Avalos, Sikhulile Moyo, Madisa Mine, Thabo Diphoko, Mosepele Mosepele, Tendani Gaolatlhe, Christopher F. Rowley, Dinah Ramaabya, Joseph N Jarvis, Ishmael Kasvosve, Simani Gaseitsiwe	2018	20
18	Strengthening Healthcare Capacity Through a Responsive, Country-Specific, Training Standard: The KITSO AIDS Training Program’s Sup-port of Botswana’s National Antiretroviral Therapy Rollout The Open AIDS Journal ·Christine Bussmann, Philip D. Rotz, Ndwapi Ndwapi, Daniel Baxter, Hermann Bussmann, C. William Wester, Patricia Ncube, Ava Avalos, Madisa Mine, Elang Mabe, Patricia Burns, Peter Cardiello, Joseph Makhema, Richard Marlink	2008	18
19	Treatment Emergent Dolutegravir Resistance Mutations in Individuals Naïve to HIV-1 Integrase Inhibitors: A Rapid Scoping Review Viruses ·Kaiming Tao, Soo‐Yon Rhee, Carolyn Chu, Ava Avalos, Amrit Ahluwalia, Ravindra K. Gupta, Michael R. Jordan, Robert W. Shafer	2023	18
20	Association of serum pepsinogen with atrophic body gastritis in Costa Rica Clinical and Experimental Medicine ·Rosa A. Sierra, Clas Une, Vanessa Ramírez, Ma. Isabel González, José Antonio Ramírez, A. de Mascarel, R Barahona, R. Salas-Aguilar, Rosela Páez, Guadalupe Guerrero Avendaño, Ava Avalos, Nathalie Broutet, Françis Mégraud	2006	18

About Ava Avalos

Ava Avalos is a scholar working on Virology, Infectious Diseases, Pediatrics, Perinatology and Child Health, Microbiology and Parasitology, having authored 27 papers that have together received 989 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (19 papers), HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (16 papers), HIV/AIDS Impact and Responses (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Tuberculosis Research and Epidemiology (2 papers), HIV, Drug Use, Sexual Risk (2 papers) and Global Maternal and Child Health (2 papers). The work is most often cited by research in Virology (488 citations), Infectious Diseases (820 citations), Emergency Medicine (102 citations), Epidemiology (297 citations) and General Health Professions (160 citations). Ava Avalos has collaborated with scholars based in United States, Botswana and United Kingdom. Frequent co-authors include Tendani Gaolathe, Max Essex, Ndwapi Ndwapi, Richard Marlink, Diana Dickinson, Hermann Bussmann, Madisa Mine, Howard Moffat, C. William Wester and Katherine Fielding. Their work appears in journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, AIDS, Viruses and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact